1. Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis
- Author
-
Eun Lee, In Suk Sol, Jong Deok Kim, Hyeon-Jong Yang, Taek Ki Min, Gwang Cheon Jang, Yoon Ha Hwang, Hyun-Ju Cho, Dong In Suh, Kyunghoon Kim, Hwan Soo Kim, Yoon Hee Kim, Sung Il Woo, Yong Ju Lee, Sungsu Jung, and You Hoon Jeon
- Subjects
Medicine ,Science - Abstract
Abstract Recurrent bacterial infection causes frequent bronchiectasis (BE) exacerbations. The effectiveness and safety of long-term administration of macrolides in BE remain controversial, especially in children who require minimal treatment to prevent exacerbation. We conducted this meta-analysis to determine the usefulness of long-term macrolide use in pediatric BE. We searched PubMed, Cochrane Library databases, Embase, KoreaMed, Igaku Chuo Zasshi, and Chinese National Knowledge Infrastructure databases. We identified randomized controlled trials (RCTs) which elucidated long-term macrolide treatment (≥ 4 weeks) in non-cystic fibrosis BE in children aged
- Published
- 2021
- Full Text
- View/download PDF